表紙
市場調查報告書

血管貼片的全球市場預測 2023年:頸動脈血管內薄膜切除術 (CEA) 、腹部主動脈血管瘤的剖腹手術、血管繞道手術

Vascular Patches Market by Material (Biologic, Synthetic), Application (Carotid Endarterectomy, Open Repair of Abdominal Aortic Aneurysms, Vascular Bypass Surgery), Patient Care Setting (Hospitals, Ambulatory Surgical Centers) - Global Forecast to 2023

出版商 MarketsandMarkets 商品編碼 652568
出版日期 內容資訊 英文 102 Pages
訂單完成後即時交付
價格
Back to Top
血管貼片的全球市場預測 2023年:頸動脈血管內薄膜切除術 (CEA) 、腹部主動脈血管瘤的剖腹手術、血管繞道手術 Vascular Patches Market by Material (Biologic, Synthetic), Application (Carotid Endarterectomy, Open Repair of Abdominal Aortic Aneurysms, Vascular Bypass Surgery), Patient Care Setting (Hospitals, Ambulatory Surgical Centers) - Global Forecast to 2023
出版日期: 2018年06月12日內容資訊: 英文 102 Pages
簡介

全球血管貼片市場規模,預計從2018年的3億4,960萬美元,到2023年達5億2,580萬美元,以8.5%的年複合成長率擴大。老年人口的劇增和血管疾病的盛行率大幅增加,血管手術實施數的增加,及生物學性貼片的引進擴大,促進該市場的成長。一般認為頸動脈血管內薄膜切除術 (CEA) 手術數的減少及產品不良、回收,今後數年將抑制市場成長。

本報告提供全球血管貼片市場相關調查,市場概要,各市場區隔、各地區的市場規模的變化與預測,競爭環境,及主要企業簡介等彙整。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 血管貼片:市場概要
  • 亞太地區:血管貼片市場,各用途
  • 血管貼片市場:各材料
  • 血管貼片市場地區概要

第5章 市場概要

  • 簡介
  • 市場動態
    • 促進要素
    • 阻礙要素
    • 機會
    • 課題
    • 趨勢

第6章 血管貼片市場:各材料

  • 簡介
  • 生物學的血管貼片
  • 手術用人工血管貼片

第7章 血管貼片市場:各用途

  • 簡介
  • 頸動脈血管內薄膜切除術 (CEA)
  • 腹部主動脈血管瘤的剖腹手術
  • 血管繞道手術
  • 其他

第8章 血管貼片市場:各終端用戶

  • 簡介
  • 醫院、診療所
  • 門診外科中心

第9章 血管貼片市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第10章 競爭環境

  • 概要
  • 主要企業排行榜
  • 競爭情形

第11章 企業簡介

  • LEMAITRE VASCULAR
  • BAXTER INTERNATIONAL
  • MAQUET (SUBSIDIARY OF GETINGE AB)
  • B.BRAUN
  • W. L. GORE & ASSOCIATES
  • ADMEDUS
  • CRYOLIFE
  • C. R. BARD
  • EDWARDS LIFESCIENCES
  • LABCOR
  • Terumo Corporation

第12章 附錄

目錄
Product Code: MD 6363

"The global vascular patches market is projected to grow at a CAGR of 8.5% during the forecast period."

The vascular patches market is expected to reach USD 525.8 million by 2023 from USD 349.6 million in 2018, at a CAGR of 8.5%. Factors such as rapidly growing geriatric population and the subsequent increase in the prevalence of vascular diseases; increasing number of vascular surgeries performed; and increasing adoption of biological patches are driving the growth of the market. The decreasing number of carotid endarterectomy surgeries and product failures and recalls are expected to limit market growth in the coming years.

"The biologic vascular patch segment is estimated to grow at the fastest rate in the next five years."

On the basis of material, the vascular patches market is segmented into biologic vascular patches and synthetic vascular patches. The biologic vascular patches segment is expected to grow at the highest CAGR during the forecast period. Growth in this market can largely be attributed to the advantages associated with the use of biologic vascular patches, such as superior biocompatibility, ease of use, minimal suture line bleeding, and reduced rates of infection in comparison with synthetic patches.

"Asia Pacific is estimated to grow at the highest CAGR during the study period."

Geographically, the vascular patches market is dominated by North America, followed by Europe in 2017. However, Asia Pacific is estimated to grow at the fastest rate due to the rising prevalence of cardiovascular diseases and the implementation of favorable government initiatives in several Asian countries. In India, for example, the central government and the Health Ministry launched the AMRIT (Affordable Medicines & Reliable Implants for Treatment) program in 2015, which enables pharmacies in government hospitals to sell various devices, cardiac implants, and cardiovascular drugs at 50-60% lower prices. Such initiatives will help boost the demand for cardiac products, including vascular patches, in the coming years.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type: Tier 1-35%, Tier 2-22% and Tier 3- 43%
  • By Designation: C level-15%, Director level-32%, Others-53%
  • By Region: North America-34%, Europe-25%, Asia Pacific-23%, Rest of the World-18%

The key players in the vascular patches market include: Terumo Corporation (Japan), C. R. Bard, Inc. (US), B. Braun Melsungen AG (Germany), LeMaitre Vascular, Inc. (US), Maquet (Germany), W. L. Gore & Associates, Inc. (US), Admedus (Australia), CryoLife, Inc. (US), Labcor Laboratorios Ltda (Brazil), Baxter International Inc. (US), and Edwards Lifesciences Corporation (US).

Research Coverage:

The report analyses the vascular patches market by material, application, end user, and region. Apart from a comprehensive geographic product analysis and market sizing, the report also provides a competitive landscape that covers growth strategies adopted by industry players over the last three years. In addition, the company profiles include product portfolios, developments, and strategies adopted by prominent market players to maintain and increase their shares in the market. Market research data, current market size, and forecast of the future trends will help key market players and new entrants make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output to remain successful.

Key Benefits of Buying the Report:

This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms garner greater market shares. Firms purchasing the report can use one or a combination of the below mentioned five strategies for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the vascular patches market
  • Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product launches in the vascular patches market
  • Competitive Assessment: In-depth assessment of the market strategies, geographic, and business segments and product portfolios of the leading players in the vascular patches market
  • Market Development: Comprehensive information about emerging markets. This report analyzes the market for various vascular patch products across geographies
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the vascular patches market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH APPROACH
  • 2.2. RESEARCH DATA
    • 2.2.1. SECONDARY SOURCES
      • 2.2.1.1. Key data from secondary sources
    • 2.2.2. PRIMARY SOURCES
      • 2.2.2.1. Key data from primary sources
  • 2.3. MARKET SIZE ESTIMATION
  • 2.4. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.5. RESEARCH ASSUMPTIONS

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. VASCULAR PATCHES: MARKET OVERVIEW
  • 4.2. ASIA PACIFIC: VASCULAR PATCHES MARKET, BY APPLICATION (2018)
  • 4.3. VASCULAR PATCHES MARKET, BY MATERIAL (2018-2023)
  • 4.4. GEOGRAPHICAL SNAPSHOT OF THE VASCULAR PATCHES MARKET

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Rapidly growing geriatric population and the subsequent increase in the prevalence of vascular diseases
      • 5.2.1.2. Increasing number of vascular surgeries performed
      • 5.2.1.3. Increasing adoption of biological patches
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Decreasing number of carotid endarterectomy surgeries
      • 5.2.2.2. Product failures and recalls
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Emerging markets
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Need for highly skilled professionals
    • 5.2.5. TRENDS
      • 5.2.5.1. Product launches and approvals

6. VASCULAR PATCHES MARKET, BY MATERIAL

  • 6.1. INTRODUCTION
  • 6.2. BIOLOGIC VASCULAR PATCHES
  • 6.3. SYNTHETIC VASCULAR PATCHES

7. VASCULAR PATCHES MARKET, BY APPLICATION

  • 7.1. INTRODUCTION
  • 7.2. CAROTID ENDARTERECTOMY
  • 7.3. OPEN REPAIR OF ABDOMINAL AORTIC ANEURYSMS
  • 7.4. VASCULAR BYPASS SURGERY
  • 7.5. OTHER APPLICATIONS

8. VASCULAR PATCHES MARKET, BY END USER

  • 8.1. INTRODUCTION
  • 8.2. HOSPITALS AND CLINICS
  • 8.3. AMBULATORY SURGICAL CENTERS

9. VASCULAR PATCHES MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. US
    • 9.2.2. CANADA
  • 9.3. EUROPE
    • 9.3.1. GERMANY
    • 9.3.2. UK
    • 9.3.3. FRANCE
    • 9.3.4. ITALY
    • 9.3.5. ROE
  • 9.4. ASIA PACIFIC
    • 9.4.1. CHINA
    • 9.4.2. JAPAN
    • 9.4.3. INDIA
    • 9.4.4. ROAPAC
  • 9.5. REST OF THE WORLD

10. COMPETITIVE LANDSCAPE

  • 10.1. OVERVIEW
  • 10.2. RANKING OF KEY PLAYERS
  • 10.3. COMPETITIVE SCENARIO
    • 10.3.1. EXPANSIONS
    • 10.3.2. PRODUCT LAUNCHES AND APPROVALS
    • 10.3.3. AGREEMENTS AND PARTNERSHIPS
    • 10.3.4. INVESTMENTS

11. COMPANY PROFILES (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

  • 11.1. LEMAITRE VASCULAR
  • 11.2. BAXTER INTERNATIONAL
  • 11.3. MAQUET (SUBSIDIARY OF GETINGE AB)
  • 11.4. B.BRAUN
  • 11.5. W. L. GORE & ASSOCIATES
  • 11.6. ADMEDUS
  • 11.7. CRYOLIFE
  • 11.8. C. R. BARD
  • 11.9. EDWARDS LIFESCIENCES
  • 11.10. LABCOR
  • 11.11. TERUMO CORPORATION

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. INSIGHTS OF INDUSTRY EXPERTS
  • 12.2. DISCUSSION GUIDE
  • 12.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 12.5. AVAILABLE CUSTOMIZATIONS
  • 12.6. RELATED REPORTS
  • 12.7. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: VASCULAR PATCHES MARKET, BY MATERIAL, 2016-2023 (USD MILLION)
  • TABLE 2: BIOLOGIC VASCULAR PATCHES MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 3: SYNTHETIC VASCULAR PATCHES MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 4: VASCULAR PATCHES MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 5: VASCULAR PATCHES MARKET FOR CAROTID ENDARTERECTOMY, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 6: VASCULAR PATCHES MARKET FOR OPEN REPAIR OF ABDOMINAL AORTIC ANEURYSM, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 7: VASCULAR PATCHES MARKET FOR VASCULAR BYPASS SURGERY, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 8: VASCULAR PATCHES MARKET FOR OTHER APPLICATIONS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 9: VASCULAR PATCHES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 10: VASCULAR PATCHES MARKET FOR HOSPITALS & CLINICS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 11: VASCULAR PATCHES MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 12: VASCULAR PATCHES MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 13: NORTH AMERICA: VASCULAR PATCHES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 14: NORTH AMERICA: VASCULAR PATCHES MARKET, BY MATERIAL, 2016-2023 (USD MILLION)
  • TABLE 15: NORTH AMERICA: VASCULAR PATCHES MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 16: NORTH AMERICA: VASCULAR PATCHES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 17: US: VASCULAR PATCHES MARKET, BY MATERIAL, 2016-2023 (USD MILLION)
  • TABLE 18: US: VASCULAR PATCHES MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 19: US: VASCULAR PATCHES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 20: CANADA: VASCULAR PATCHES MARKET, BY MATERIAL, 2016-2023 (USD MILLION)
  • TABLE 21: CANADA: VASCULAR PATCHES MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 22: CANADA: VASCULAR PATCHES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 23: EUROPE: VASCULAR PATCHES MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 24: EUROPE: VASCULAR PATCHES MARKET, BY MATERIAL, 2016-2023 (USD MILLION)
  • TABLE 25: EUROPE: VASCULAR PATCHES MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 26: EUROPE: VASCULAR PATCHES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 27: GERMANY: VASCULAR PATCHES MARKET, BY MATERIAL, 2016-2023 (USD MILLION)
  • TABLE 28: GERMANY: VASCULAR PATCHES MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 29: GERMANY: VASCULAR PATCHES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 30: UK: VASCULAR PATCHES MARKET, BY MATERIAL, 2016-2023 (USD MILLION)
  • TABLE 31: UK: VASCULAR PATCHES MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 32: UK: VASCULAR PATCHES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 33: FRANCE: VASCULAR PATCHES MARKET, BY MATERIAL, 2016-2023 (USD MILLION)
  • TABLE 34: FRANCE: VASCULAR PATCHES MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 35: FRANCE: VASCULAR PATCHES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 36: ITALY: VASCULAR PATCHES MARKET, BY MATERIAL, 2016-2023 (USD MILLION)
  • TABLE 37: ITALY: VASCULAR PATCHES MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 38: ITALY: VASCULAR PATCHES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 39: ROE: VASCULAR PATCHES MARKET, BY MATERIAL, 2016-2023 (USD MILLION)
  • TABLE 40: ROE: VASCULAR PATCHES MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 41: ROE: VASCULAR PATCHES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 42: APAC: VASCULAR PATCHES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 43: APAC: VASCULAR PATCHES MARKET, BY MATERIAL, 2016-2023 (USD MILLION)
  • TABLE 44: APAC: VASCULAR PATCHES MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 45: APAC: VASCULAR PATCHES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 46: CHINA: VASCULAR PATCHES MARKET, BY MATERIAL, 2016-2023 (USD MILLION)
  • TABLE 47: CHINA: VASCULAR PATCHES MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 48: CHINA: VASCULAR PATCHES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 49: JAPAN: VASCULAR PATCHES MARKET, BY MATERIAL, 2016-2023 (USD MILLION)
  • TABLE 50: JAPAN: VASCULAR PATCHES MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 51: JAPAN: VASCULAR PATCHES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 52: INDIA: VASCULAR PATCHES MARKET, BY MATERIAL, 2016-2023 (USD MILLION)
  • TABLE 53: INDIA: VASCULAR PATCHES MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 54: INDIA: VASCULAR PATCHES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 55: ROAPAC: VASCULAR PATCHES MARKET, BY MATERIAL, 2016-2023 (USD MILLION)
  • TABLE 56: ROAPAC: VASCULAR PATCHES MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 57: ROAPAC: VASCULAR PATCHES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 58: ROW: VASCULAR PATCHES MARKET, BY MATERIAL, 2016-2023 (USD MILLION)
  • TABLE 59: ROW: VASCULAR PATCHES MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 60: ROW: VASCULAR PATCHES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 61: RANKING OF COMPANIES IN THE GLOBAL VASCULAR PATCHES MARKET (2017)
  • TABLE 62: EXPANSIONS, 2015-2018
  • TABLE 63: PRODUCT LAUNCHES AND APPROVALS, 2015-2018
  • TABLE 64: AGREEMENTS AND PARTNERSHIPS, 2015-2018
  • TABLE 65: INVESTMENTS, 2015-2018

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 4: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: VASCULAR PATCHES MARKET, BY MATERIAL, 2018 VS. 2023 (USD MILLION)
  • FIGURE 7: VASCULAR PATCHES MARKET, BY APPLICATION, 2018 VS. 2023 (USD MILLION)
  • FIGURE 8: VASCULAR PATCHES MARKET, BY END USER, 2018 VS. 2023 (USD MILLION)
  • FIGURE 9: VASCULAR PATCHES MARKET, BY REGION, 2018 VS. 2023 (USD MILLION)
  • FIGURE 10: EMERGING MARKETS TO OFFER A WIDE RANGE OF GROWTH OPPORTUNITIES FOR MARKET PLAYERS
  • FIGURE 11: CAROTID ENDARTERECTOMY TO DOMINATE THE ASIA PACIFIC VASCULAR PATCHES MARKET IN 2018
  • FIGURE 12: BIOLOGIC VASCULAR PATCHES TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
  • FIGURE 13: CHINA & INDIA TO WITNESS THE HIGHEST GROWTH RATES IN THE VASCULAR PATCHES MARKET DURING THE STUDY PERIOD
  • FIGURE 14: VASCULAR PATCHES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, CHALLENGES, & TRENDS
  • FIGURE 15: GLOBAL GERIATRIC POPULATION (60 YEARS AND ABOVE), 2015 VS. 2030
  • FIGURE 16: BIOLOGIC VASCULAR PATCHES TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
  • FIGURE 17: CAROTID ENDARTERECTOMY, THE LARGEST APPLICATION SEGMENT IN THE MARKET IN 2018
  • FIGURE 18: HOSPITALS AND CLINICS ARE ESTIMATED TO BE THE LARGEST END USERS OF VASCULAR PATCHES IN 2018
  • FIGURE 19: NORTH AMERICA IS ESTIMATED TO DOMINATE THE VASCULAR PATCHES MARKET IN 2018
  • FIGURE 20: NORTH AMERICA: MARKET SNAPSHOT
  • FIGURE 21: ASIA PACIFIC: MARKET SNAPSHOT
  • FIGURE 22: EXPANSIONS WERE THE KEY STRATEGIES ADOPTED BY PLAYERS BETWEEN 2015 AND 2018
  • FIGURE 23: LEMAITRE VASCULAR: COMPANY SNAPSHOT (2017)
  • FIGURE 24: BAXTER INTERNATIONAL: COMPANY SNAPSHOT (2017)
  • FIGURE 25: GETINGE AB: COMPANY SNAPSHOT (2017)
  • FIGURE 26: B. BRAUN: COMPANY SNAPSHOT (2017)
  • FIGURE 27: ADMEDUS: COMPANY SNAPSHOT (2017)
  • FIGURE 28: CRYOLIFE: COMPANY SNAPSHOT (2017)
  • FIGURE 29: C. R. BARD: COMPANY SNAPSHOT (2016)
  • FIGURE 30: EDWARDS LIFESCIENCES: COMPANY SNAPSHOT (2017)
  • FIGURE 31: TERUMO: COMPANY SNAPSHOT (2016)
Back to Top